Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board

Dr. Ivor Royston, Oncologist, Scientist, Entrepreneur-Financier and Founding Father of San Diego Biotech, Joins MMRGlobal Board

LOS ANGELES, CA — (Marketwired) — 05/28/13 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that Ivor Royston, M.D. has agreed to join the Company-s Board of Directors effective immediately. MMR-s Board of Directors voted unanimously to authorize management of the Company to extend an invitation to Dr. Royston to serve on the Board. MMR-s management and the Board believe it is in the best interest of the Company and its stockholders to have a director whose exper

MMRGlobal Awarded Another International Patent to Fight Cancer, Company Benefits From Worldwide HIT & Biotech Patents

MMRGlobal Awarded Another International Patent to Fight Cancer, Company Benefits From Worldwide HIT & Biotech Patents

LOS ANGELES, CA — (Marketwired) — 04/22/13 — (OTCQB: MMRF) ("MMR") today announced that the Australian Patent Office has issued a Notice of Allowance (NOA) for the Company-s anti-CD20 monoclonal antibody assets, #2007338607, under the title, "Antibodies and Methods for Making and Using Them." The patent application was originally filed on September 14, 2007. The Australian NOA is significant to the Company in that it reinforces the value of the U.S. antibody patent that